Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Husain, Mansoor, Birkenfeld, Andreas L, Donsmark, Morten, Dungan, Kathleen, Eliaschewitz, Freddy G, Franco, Denise R, Jeppesen, Ole K, Lingvay, Ildiko, Mosenzon, Ofri, Pedersen, Sue D, Tack, Cees J, Thomsen, Mette, Vilsbøll, Tina, Warren, Mark L, Bain, Stephen C
Published in The New England journal of medicine (29.08.2019)
Published in The New England journal of medicine (29.08.2019)
Get full text
Journal Article
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, Steven P, Bain, Stephen C, Consoli, Agostino, Eliaschewitz, Freddy G, Jódar, Esteban, Leiter, Lawrence A, Lingvay, Ildiko, Rosenstock, Julio, Seufert, Jochen, Warren, Mark L, Woo, Vincent, Hansen, Oluf, Holst, Anders G, Pettersson, Jonas, Vilsbøll, Tina
Published in The New England journal of medicine (10.11.2016)
Published in The New England journal of medicine (10.11.2016)
Get full text
Journal Article
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Ahrén, Bo, Atkin, Stephen L., Charpentier, Guillaume, Warren, Mark L., Wilding, John P. H., Birch, Sune, Holst, Anders Gaarsdal, Leiter, Lawrence A.
Published in Diabetes, obesity & metabolism (01.09.2018)
Published in Diabetes, obesity & metabolism (01.09.2018)
Get full text
Journal Article
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
Mannstadt, Michael, Clarke, Bart L, Bilezikian, John P, Bone, Henry, Denham, Douglas, Levine, Michael A, Peacock, Munro, Rothman, Jeffrey, Shoback, Dolores M, Warren, Mark L, Watts, Nelson B, Lee, Hak-Myung, Sherry, Nicole, Vokes, Tamara J
Published in The journal of clinical endocrinology and metabolism (01.11.2019)
Published in The journal of clinical endocrinology and metabolism (01.11.2019)
Get full text
Journal Article
932-P: Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program
ARODA, VANITA R., BAUER, ROBERT, HERTZ, CHRISTIN L., MONTANYA, EDUARD, SØRRIG, RASMUS, WARREN, MARK L., CARIOU, BERTRAND
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
1904-LB: Glycemic Improvement with Use of the Omnipod 5 Automated Insulin Delivery System in Adults with Type 2 Diabetes—Results of the SECURE-T2D Pivotal Trial
PASQUEL, FRANCISCO J., DAVIS, GEORGIA M., HUFFMAN, DAVID M., PETERS, ANNE L., PARKER, JOHN C., LAFFEL, LORI M., MATHEW, JUSTIN, CASTORINO, KRISTIN N., KRUGER, DAVIDA F., DUNGAN, KATHLEEN M., KIPNES, MARK, JAUCH, EDWARD, OSER, TAMARA, SHAH, VIRAL N., HOROWITZ, BARRY, CARLSON, ANDERS L., WARREN, MARK L., DEEB, WASIM, BUSE, JOHN B., REED, JOHN H., BERNER, JASON, BLEVINS, THOMAS, BAJAJ, CHRIS, KOLLMAN, CRAIG, RAGHINARU, DAN, LY, TRANG T., BECK, ROY W., SECURE-T2D STUDY CONSORTIUM, THE
Published in Diabetes (New York, N.Y.) (21.06.2024)
Published in Diabetes (New York, N.Y.) (21.06.2024)
Get full text
Journal Article
Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes
Warren, Mark L., Brod, Meryl, Håkan-Bloch, Jonas, Sparre, Thomas, Chaykin, Louis B.
Published in Current medical research and opinion (02.09.2019)
Published in Current medical research and opinion (02.09.2019)
Get full text
Journal Article
EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETES
Wysham, Carol, Hood, Robert C, Warren, Mark L, Wang, Tao, Morwick, Tina M, Jackson, Jeffrey A
Published in Endocrine practice (01.06.2016)
Published in Endocrine practice (01.06.2016)
Get full text
Journal Article
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
Watts, Nelson B, Bilezikian, John P, Bone, Henry G, Clarke, Bart L, Denham, Douglas, Levine, Michael A, Mannstadt, Michael, Peacock, Munro, Rothman, Jeffrey G, Vokes, Tamara J, Warren, Mark L, Yin, Shaoming, Sherry, Nicole, Shoback, Dolores M
Published in Journal of the Endocrine Society (06.03.2023)
Published in Journal of the Endocrine Society (06.03.2023)
Get full text
Journal Article
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
Warren, Mark L, Chaykin, Louis B, Jabbour, Serge, Sheikh-Ali, Mae, Hansen, Charlotte T, Nielsen, Thor S S, Norwood, Paul
Published in Clinical diabetes (01.04.2017)
Published in Clinical diabetes (01.04.2017)
Get full text
Journal Article
Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare)
Bode, Bruce W, Chaykin, Louis B, Sussman, Allen M, Warren, Mark L, Niemeyer, Marcus, Rabøl, Rasmus, Rodbard, Helena W
Published in Endocrine practice (01.08.2014)
Published in Endocrine practice (01.08.2014)
Get full text
Journal Article
945-P: Safety and Glycemic Outcomes of Adults with Type 2 Diabetes (T2D) in a MiniMed Advanced Hybrid Closed-Loop (AHCL) System Trial
Bhargava, Anuj, Thrasher, James, Bode, Bruce W, Warren, Mark L, Bergenstal, Richard M, Dempsey, Michael, Reed, John H, Ma, Haoxi, Keiter, Ashleigh, Cordero, Toni L, Mcvean, Jennifer, Shin, John, Rhinehart, Andrew S, Vigersky, Robert A
Published in Diabetes (New York, N.Y.) (01.06.2024)
Published in Diabetes (New York, N.Y.) (01.06.2024)
Get full text
Journal Article
Effect of Total Daily Dose on Efficacy, Dosing, and Safety of 2 Dose Titration Regimens of Human Regular U-500 Insulin in Severely Insulin-Resistant Patients with Type 2 Diabetes
Wysham, Carol, Hood, Robert C., Warren, Mark L., Wang, Tao, Morwick, Tina M., Jackson, Jeffrey A.
Published in Endocrine practice (01.06.2016)
Published in Endocrine practice (01.06.2016)
Get full text
Journal Article
61 - Comparable Efficacy of Once-Weekly Subcutaneous Semaglutide in Subjects With Type 2 Diabetes Aged <65 and ≥65 Years: SUSTAIN 1–5 and 7–10 Posthoc Analysis
Jain, Akshay, Warren, Mark L., Hindsberger, Charlotte, Lawson, Jack, Ludvik, Bernhard, Pilemann-Lyberg, Sascha, Viljoen, Adie
Published in Canadian journal of diabetes (01.10.2020)
Published in Canadian journal of diabetes (01.10.2020)
Get full text
Journal Article
57 - Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program
Pedersen, Sue, Aroda, Vanita R., Bauer, Robert, Hertz, Christin Løth, Montanya, Eduard, Warren, Mark L., Cariou, Bertrand
Published in Canadian journal of diabetes (01.10.2020)
Published in Canadian journal of diabetes (01.10.2020)
Get full text
Journal Article